# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Explore the €6 billion financing effort by banks for Sanofi's consumer health division sale. Discover the latest in high-st...
- Bloomberg
Senator Bernie Sanders is pushing Novo Nordisk to lower U.S. prices for weight-loss drugs Ozempic and Wegovy, as part of a broa...
Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices,...
- Bloomberg
EMA approves Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled COPD characterized by raised ...
A Delaware judge dismissed GSK and other drugmakers' appeal, allowing over 70,000 lawsuits alleging Zantac causes cancer to...
Sanofi is set to invest up to $1.6 billion in its Frankfurt insulin production site, marking a significant win for Germany'...
Frexalimab new phase 2 data showed reduction of key biomarker of nerve cell damage in relapsing MSFrexalimab high-dose arm obse...